Overview
Introduction
Atopic dermatitis develops through interaction between barrier dysfunction and immune activation.
Atopic dermatitis develops through interaction between barrier dysfunction and immune activation. Barrier impairment allows increased transepidermal water loss and easier penetration of irritants, allergens, and microorganisms. This stimulates cutaneous immune activation, particularly type 2 inflammatory pathways in many clients. Inflammation then increases pruritus, erythema or pigment change, edema, scaling, oozing, crusting, and epidermal thickening. Scratching further damages the skin barrier, which perpetuates the itch–scratch cycle. The itch–scratch cycle is central to disease persistence: Impaired barrier → dryness and irritant entry. Irritant/allergen exposure → immune activation. Inflammation → pruritus and visible dermatitis. Scratching/rubbing → excoriations and barrier breakdown. Barrier breakdown → more inflammation, microbial entry, and itch. For NP learners, the key concept is that pruritus is not merely a symptom; it is a disease amplifier. Severe itch drives sleep loss, excoriation, lichenification, infection risk, impaired concentration, mental health burden, and caregiver exhaustion. Treating itch requires controlling inflammation, restoring the barrier, reducing triggers, preventing scratching injury, and addressing sleep disruption. For Canadian NP practice / CNPLE-aligned preparation (Canada), items rarely announce the topic in the first sentence. Anchor to objective data,...